Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators will assess the efficacy of Pivotal Response Treatment (PRT) in the treatment of communication deficits in children with intellectual disabilities. By collecting information about parent and child functioning before and after PRT, The investigators will be able to determine whether the intervention is effective in improving child communication and reducing parent stress.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pivotal Response Treatment (PRT) | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pivotal Response Treatment (PRT) | Behavioral |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline on the MacArthur-Bates Communication Development Inventory at 6, 12, and 24 weeks | 6, 12 and 24 weeks | |
| Change from Baseline in communication during parent-child and clinician-child interactions at 6, 12, and 24 weeks | 6, 12 and 24 weeks | |
| Change from Baseline on the Social Responsiveness Scale (SRS) at 6, 12, and 24 weeks | 6, 12 and 24 weeks | |
| Change from Baseline on the Clinical Global Impression Scale at 6, 12, and 24 weeks | 6, 12, and 24 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline on the Vineland Adaptive Behavior Scales, Second Edition (VABS-II) at 6, 12, and 24 weeks | 6, 12 and 24 weeks | |
| Change from Baseline on the Parenting Stress Index (PSI) at 6, 12, and 24 weeks | 6, 12, and 24 weeks |
Not provided
Inclusion Criteria for Individuals with Intellectual Disabilities:
Inclusion Criteria for Individuals with Speech Delay/Language Disorder:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Antonio Y. Hardan, M.D. | Stanford University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stanford University School of Medicine | Stanford | California | 94305-5719 | United States |
Not provided
| ID | Term |
|---|---|
| D008607 | Intellectual Disability |
| D007805 | Language Development Disorders |
| D007806 | Language Disorders |
| ID | Term |
|---|---|
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Change from Baseline on the Family Empowerment Scale (FES) at 6, 12, and 24 weeks | 6, 12, and 24 weeks |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D065886 | Neurodevelopmental Disorders |
| D001523 | Mental Disorders |
| D003147 | Communication Disorders |